NCT04789356View on ClinicalTrials.gov

Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity

PHASE4UnknownINTERVENTIONAL
Enrollment

6,233

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

July 5, 2021

Study Completion Date

March 31, 2022

Conditions
Covid19
Interventions
BIOLOGICAL

Adsorbed SARS-CoV-2 (inactivated) vaccine

600 SU/dose; Two doses separated by 28 days (± 7 days). Intramuscular (deltoid) administration.

Trial Locations (1)

69050-010

Escola Normal Superior - Universidade do Estado do Amazonas, Manaus

Sponsors

Collaborators (1)

Butantan Institute
All Listed Sponsors
collaborator

Butantan Institute

OTHER_GOV

lead

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado

OTHER